Luka Rotkvić

Clinical effectiveness of primary prevention implantable cardioverter-defibrillators: results of the EU-CERT-ICD controlled multicentre cohort study

Markus Zabel, Rik Willems, Andrzej Lubiński et al. · European Heart Journal · 2020 · 154 citations · Full text

Medicine, Cardiology, Cardiothoracic Surgery +13

Appropriate Shocks and Mortality in Patients With Versus Without Diabetes With Prophylactic Implantable Cardioverter Defibrillators

Juhani Junttila, Ari Pelli, Tuomas Kenttä et al. · Diabetes Care · 2019 · 16 citations · Full text

Medicine, Cardiology, Internal Medicine +12

Prevention of cardiac allograft vasculopathy – A new possible indication for SGLT-2 inhibitors?

Petra Grubić Rotkvić, Maja Cigrovski Berković, Luka Rotkvić et al. · Medical Hypotheses · 2020 · 12 citations

Medicine, Cardiology, Pharmacotherapy +15

Q waves are the strongest electrocardiographic variable associated with primary prophylactic implantable cardioverter-defibrillator benefit: a prospective multicentre study

Ari Pelli, Juhani Junttila, Tuomas Kenttä et al. · EP Europace · 2021 · 11 citations · Full text

Medicine, Cardiology, Clinical Cardiology +16